Biosimilars are developed to be highly similar versions of approved biologics in terms of safety, purity, and potency. Biosimilars are expected to be a cost-effective alternative to high-priced branded biologics, […]readmore
Tags : STADA
Shots: STADA to acquire Biopharma’s pharmaceutical prescription and consumer health business including local manufacturing operations and ~300 new staff. Biopharma will retain its blood plasma-based business and will focus on […]readmore
1. Triumvira’s TAC01-CD19 Receives FDA’s Fast Track Designation for R/R Diffuse Large B-Cell Lymphoma Published: Nov 07, 2019 | Tags: Triumvira, TAC01-CD19, Receives, FDA, Fast Track Designation, R/R, Diffuse Large B-Cell […]readmore
Shots: Alvotech to receive up front with subsequent milestones for the next five years. STADA to get exclusive right to commercialize seven biosimilars in all key European markets and selected […]readmore
Shots: Takeda to receive ~$660M for divesting its 20 select prescription pharmaceutical and OTC products traded in Russia, Georgia, and several countries within the Commonwealth of Independent States. STADA to […]readmore
The global generics pharmaceutical market is continuously growing and increasing with its accessibility & benefits offered as efficient and economical drugs, are always needed in the market. Generics are approved […]readmore
Biosimilars are key alternatives for costly Biologics therapies and saving million dollars of patients in multiple diseases. Hence physicians are likely to adopt biosimilars “a reference product to biologics” possessing […]readmore
Shots: In early H2’19, STADA is launching its biosimilar teriparatide, Movymia as a cost-effective with the patent expiration of the reference product Forsteo leading to expansion of STADA’s biosimilar portfolio […]readmore
Shots: STADA acquires GSK’s six brands containing five skin care/topical application and one pediatric cough remedy namely Oilatum, Eurax, Savlon Antiseptic Cream, Ceridal, Tixylix and Polytar. The transaction is expected […]readmore